Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in South Korea / NCT07558876
Recruiting Not applicable

Task-Oriented Upper Limb Training With Focal Vibration in Stroke

NCT07558876 · tracked via the Priya Life Science South Korea tracker
Sponsor
Jisu Kim
Phase
Not applicable
Started
2026-04-27
Last updated
2026-04-30

Condition(s) studied

Stroke

Investigational drug(s) / intervention(s)

ask-oriented upper limb training combined with focal vibrationActive Comparator: Task-Oriented Upper Limb Training Alone

ask-oriented upper limb training combined with focal vibration: Participants in the experimental group will receive task-oriented upper limb training combined with focal vibration applied to the wrist extensor muscles during task performance. The intervention will be administered for 30 minutes per session, 2 times per week, for 6 weeks, and no vibration will be applied during rest periods.

Active Comparator: Task-Oriented Upper Limb Training Alone: Participants in the control group will receive task-oriented upper limb training without the application of focal vibration, with the device attached to the wrist extensor muscles. The intervention will be administered for 30 minutes per session, 2 times per week, for 6 weeks.

Study summary

This study aims to investigate the effects of task-oriented upper limb training combined with focal vibration on hand function, proprioception, and muscle tone in patients with stroke. Participants will be randomly assigned to either an experimental group receiving task-oriented training with concurrent focal vibration or a control group receiving task-oriented training alone. The intervention will be conducted over 6 weeks. Outcome measures will be assessed before and after the intervention.

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Individuals diagnosed with stroke at least 3 months prior * Individuals with sufficient cognitive function (Mini-Mental State Examination \[MMSE\] score ≥ 24) * Individuals able to maintain a seated position independently and perform upper limb functional tasks (Trunk Control Test \[TCT\] ≥ 50) * Individuals with muscle tone of the affected upper limb of Modified Ashworth Scale (MAS) Grade ≤ 2 * Individuals with Fugl-Meyer Assessment-Upper Extremity (FMA-UE) scores between 20 and 50 * Individuals able to grasp and move objects with the affected upper limb and with muscle strength of Manual Muscle Test (MMT) Grade ≥ 3 * Individuals with impaired proprioception in the affected hand (defined as a score \< 2 on the wrist or thumb position item of the FMA-UE) Exclusion Criteria: * Individuals within 3 months after stroke onset * Individuals with fractures, severe soft tissue injuries, or contraindications to focal vibration * Individuals with severe sensory hypersensitivity or complex regional pain syndrome (CRPS) * Individuals who received treatments affecting upper limb function within the past 3 months (e.g., botulinum toxin injection, surgery, nerve block)

Primary outcome measure(s)

  • Fugl-Meyer Assessment for Upper Extremity (FMA-UE) — Baseline and immediately after 6 weeks of intervention
    The Fugl-Meyer Assessment for Upper Extremity (FMA-UE) will be used to evaluate motor function of the affected upper limb. The total score ranges from 0 to 66, with higher scores indicating better motor function.

Trial sites (2)

FacilityCityRegionStatus
Cheongdam Hospital Seoul South Korea Recruiting
Sahmyook University Seoul South Korea Not Yet Recruiting

Other trials for the same condition

Korean Stroke Cohort for Functioning and Rehabilitation-II Active, not recruiting
Efficacy of Personalized Repetitive Transcranial Magnetic Stimulation Protocol Based on Functional Reserve to Enhance Upper Limb Function in Subacute Stroke Patients Recruiting
Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study Recruiting
Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation Active, not recruiting
Prefrontal Brain Activity and ECG Patterns in Stroke and Healthy Adults Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07558876 on ClinicalTrials.gov ↗ ← All trials in South Korea